Point-of-care diagnostics for invasive aspergillosis: nearing the finish line

References

• Salzer HJF, Prattes J, Hoenigl M. Editorial: diagnostic approaches for aspergillus infections. Front Microbiol. 2019;10:446.
   PubMed Web of Science ®Google Scholar
• Geiser DM. Sexual structures in Aspergillus: morphology, importance and genomics. Med Mycol. 2009;47(Suppl 1):S21–6.
   PubMedGoogle Scholar
• Latgé JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev. 1999 Apr;12(2):310–350.
   PubMed Web of Science ®Google Scholar
• Bongomin F, Gago S, Oladele RO, et al. Global and multi-national prevalence of fungal diseases-estimate precision. J Fungi (Basel). 2017 Oct 18;3:4.
   Google Scholar
• Barton RC. Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome. Scientifica. 2013;2013:459405.
   PubMedGoogle Scholar
• Lewis RE, Cahyame-Zuniga L, Leventakos K, et al. Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study. Mycoses. 2013 Nov;56(6):638–645.
   PubMed Web of Science ®Google Scholar
• Shojania KG, Burton EC. The vanishing nonforensic autopsy. N Engl J Med. 2008 Feb 28;358(9):873–875.
   PubMed Web of Science ®Google Scholar
• Patterson TF. Risk stratification for invasive aspergillosis: early assessment of host susceptibility. Med Mycol. 2009;47(Suppl 1):S255–60.
   PubMedGoogle Scholar
• Cornely OA, Lass-Florl C, Lagrou K, et al. Improving outcome of fungal diseases - Guiding experts and patients towards excellence. Mycoses. 2017 Jul;60(7):420–425.
   PubMed Web of Science ®Google Scholar
• Jenks JD, Salzer HJF, Hoenigl M. Improving the rates of Aspergillus detection: an update on current diagnostic strategies. Expert rev anti-infective ther. 2019 Jan;17(1):39–50.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Salzer HJ, Raggam RB, et al. Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies. Med Mycol. 2012 Apr;50(3):266–269.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Seeber K, Koidl C, et al. Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy. Mycoses. 2013 Jul;56(4):471–476.
   PubMed Web of Science ®Google Scholar
• Eigl S, Hoenigl M, Spiess B, et al. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis. Med Mycol. 2017 Jul 1;55(5):528–534.
   PubMed Web of Science ®Google Scholar
• Rawlings SA, Heldt S, Prattes J, et al. Using interleukin 6 and 8 in blood and bronchoalveolar lavage fluid to predict survival in hematological malignancy patients with suspected pulmonary mold infection. Front Immunol. 2019;10:1798.
   PubMed Web of Science ®Google Scholar
• Zhou W, Li H, Zhang Y, et al. Diagnostic value of galactomannan antigen test in serum and bronchoalveolar lavage fluid samples from patients with nonneutropenic invasive pulmonary aspergillosis. J Clin Microbiol. 2017 Jul;55(7):2153–2161.
   PubMed Web of Science ®Google Scholar
• Heldt S, Prattes J, Eigl S, et al. Diagnosis of invasive aspergillosis in hematological malignancy patients: performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples. J Infect. 2018;77(3): 235–241.
   PubMed Web of Science ®Google Scholar
• de Heer K, Gerritsen MG, Visser CE, et al. Galactomannan detection in broncho-alveolar lavage fluid for invasive aspergillosis in immunocompromised patients. Cochrane Database Syst Rev. 2019 May 20;5:Cd012399.
   PubMedGoogle Scholar
• Schauwvlieghe AFAD, de Jonge N, van Dijk K, et al. The diagnosis and treatment of invasive aspergillosis in Dutch haematology units facing a rapidly increasing prevalence of azole-resistance. A nationwide survey and rationale for the DB-MSG 002 study protocol. Mycoses. 2018;61(9):656–664.
   PubMed Web of Science ®Google Scholar
• Prattes J, Valentin T, Hoenigl M, et al. Invasive pulmonary aspergillosis complicating COVID-19 in the ICU - A case report. Med Mycol Case Rep. 2020 May 11; DOI:10.1016/j.mmcr.2020.05.001
   PubMed Web of Science ®Google Scholar
• Verweij PE, Gangneux J-P, Bassetti M, et al. Diagnosing COVID-19-associated pulmonary aspergillosis. Lancet Microbe. 2020;1(2):e53–e55. DOI:10.1016/S2666-5247(20)30027-6
   Google Scholar
• Koehler P, Cornely OA, Böttiger BW, et al. COVID-19 associated pulmonary aspergillosis. Mycoses. 2020 Jun;63(6):528–534.
   PubMed Web of Science ®Google Scholar
• Thompson GR III, Cornely OA, Pappas PG, et al. Invasive aspergillosis as an underrecognized superinfection in COVID-19. Open Forum Infect Dis. 2020;7(7). DOI:10.1093/ofid/ofaa242.
   PubMed Web of Science ®Google Scholar
• Arastehfar A, Carvalho A, van de Veerdonk FL, et al. COVID-19 associated pulmonary aspergillosis (CAPA)-from immunology to treatment. J Fungi (Basel). 2020 Jun 24;6:2.
   Google Scholar
• Jenks JD, Mehta SR, Taplitz R, et al. Point-of-care diagnosis of invasive aspergillosis in non-neutropenic patients: aspergillus Galactomannan lateral flow assay versus aspergillus-specific lateral flow device test in bronchoalveolar lavage. Mycoses. 2019 Mar;62(3):230–236.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Giacobbe DR, Grecchi C, et al. Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: A systematic review with qualitative evidence synthesis. J infect. 2020 Apr 21;81(1):131–146.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Scudeller L, Giacobbe DR, et al. Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project. Mycoses. 2019 Apr;62(4):310–319.
   PubMed Web of Science ®Google Scholar
• Fortun J, Martin-Davila P, Gomez Garcia de la Pedrosa E, et al. Galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive aspergillosis in non-hematological patients. J Infect. 2016 Jun;72(6):738–744.
   PubMed Web of Science ®Google Scholar
• Prattes J, Flick H, Pruller F, et al. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases. Am J Respir Crit Care Med. 2014;190(8):922–929.
   PubMed Web of Science ®Google Scholar
• Martinelli AW, Patil P, Wong VK, et al. A positive BAL galactomannan in non-haemato-oncology patients risks harmful overtreatment. J Med Microbiol. 2019 Dec;68(12):1766–1770.
   PubMed Web of Science ®Google Scholar
• Unterman A, Izhakian S, Geffen Y, et al. Routine comprehensive Aspergillus screening of bronchoalveolar lavage samples in lung transplant recipients. Clin Transplant. 2020 Mar;34(3):e13811.
   PubMed Web of Science ®Google Scholar
• Buchheidt D, Reinwald M, Hoenigl M, et al. The evolving landscape of new diagnostic tests for invasive aspergillosis in hematology patients: strengths and weaknesses. Curr Opin Infect Dis. 2017 Dec;30(6):539–544.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Prattes J, Neumeister P, et al. Real-world challenges and unmet needs in the diagnosis and treatment of suspected invasive pulmonary aspergillosis in patients with haematological diseases: an illustrative case study. Mycoses. 2018 Mar;61(3):201–205.
   PubMed Web of Science ®Google Scholar
• Springer J, Lackner M, Nachbaur D, et al. Prospective multicentre PCR-based Aspergillus DNA screening in high-risk patients with and without primary antifungal mould prophylaxis. Clin Microbiol Infect. 2016 Jan;22(1):80–86.
   PubMed Web of Science ®Google Scholar
• Reinwald M, Hummel M, Kovalevskaya E, et al. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. J Antimicrob Chemother. 2012 Sep;67(9):2260–2267.
   PubMed Web of Science ®Google Scholar
• Guenter S, Gorkiewicz G, Halwachs B, et al. Impact of ITS-Based Sequencing on Antifungal Treatment of Patients with Suspected Invasive Fungal Infections. J Fungi (Basel). 2020;6(2):43. DOI:10.3390/jof6020043
   PubMedGoogle Scholar
• Jenks JD, Spiess B, Buchheidt D, et al. New) methods for detection of aspergillus fumigatus resistance in clinical samples. Curr Fungal Infect Rep. 2019 Sep;13(3):129–136.
   PubMed Web of Science ®Google Scholar
• White PL, Bretagne S, Klingspor L, et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol. 2010 Apr;48(4):1231–1240.
   PubMed Web of Science ®Google Scholar
• White PL, Wingard JR, Bretagne S, et al. Aspergillus polymerase chain reaction: systematic review of evidence for clinical use in comparison with antigen testing. Clin Infect Dis. 2015 Oct 15;61(8):1293–1303.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Hoenigl M, Lass-Florl C, et al. Defining breakthrough invasive fungal infection-position paper of the mycoses study group education and research consortium and the european confederation of medical mycology. Mycoses. 2019 Sep;62(9):716–729.
   PubMed Web of Science ®Google Scholar
• Egger M, Jenks JD, Hoenigl M, et al. Blood aspergillus PCR: the good, the bad, and the ugly. J Fungi. 2020;6(1):E18.
   Web of Science ®Google Scholar
• Arvanitis M, Ziakas PD, Zacharioudakis IM, et al. PCR in diagnosis of invasive aspergillosis: a meta-analysis of diagnostic performance. J Clin Microbiol. 2014 Oct;52(10):3731–3742.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Orasch T, Faserl K, et al. Triacetylfusarinine C: A urine biomarker for diagnosis of invasive aspergillosis. J Infect. 2019 Feb;78(2):150–157.
   PubMed Web of Science ®Google Scholar
• Jenks JD, Rawlings SA, Garcia-Vidal C, et al. Immune parameters for diagnosis and treatment monitoring in invasive mold infection. J Fungi. 2019;5(4):E116.
   Web of Science ®Google Scholar
• Mercier T, Guldentops E, Lagrou K, et al. Prospective evaluation of the turbidimetric β-D-glucan assay and two lateral flow assays on serum in invasive aspergillosis. Clin Infect Dis. 2020 Mar 19. DOI:10.1093/cid/ciaa295.
   PubMedGoogle Scholar
• Jenks JD, Mehta SR, Taplitz R, et al. Bronchoalveolar lavage aspergillus galactomannan lateral flow assay versus aspergillus-specific lateral flow device test for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies. J Infect. 2019 Mar;78(3):249–259.
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C, Lo Cascio G, Nucci M, et al. Respiratory specimens and the diagnostic accuracy of Aspergillus lateral flow assays (LFA-IMMY™): real-life data from a multicentre study. Clin Microbiol Infect. 2019;25(12):1563.e1-1563.e3.
   Web of Science ®Google Scholar
• Mercier T, Dunbar A, de Kort E, et al. Lateral flow assays for diagnosing invasive pulmonary aspergillosis in adult hematology patients: A comparative multicenter study. Med Mycol. 2020;58(4):444–452. DOI:10.1093/mmy/myz079
   Google Scholar
• Hoenigl M, Eigl S, Heldt S, et al. Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis. Mycoses. 2018;61(1):40–43.
   PubMed Web of Science ®Google Scholar
• Heldt S, Hoenigl M. Lateral flow assays for the diagnosis of invasive aspergillosis: current status. Curr fungal infect rep. 2017;11(2):45–51.
   PubMed Web of Science ®Google Scholar
• Eigl S, Prattes J, Lackner M, et al. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients. Crit Care. 2015;19(1): 178-015-0905–x. DOI:10.1186/s13054-015-0905-x.
   PubMedGoogle Scholar
• Prattes J, Lackner M, Eigl S, et al. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients. Mycoses. 2015;58(8):461–469.
   PubMed Web of Science ®Google Scholar
• Willinger B, Lackner M, Lass-Florl C, et al. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis in solid organ transplant patients: a semiprospective multicenter study. Transplantation. 2014 Oct 27;98(8):898–902.
   PubMed Web of Science ®Google Scholar
• Rolle AM, Hasenberg M, Thornton CR, et al. ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo. Proc Natl Acad Sci U S A. 2016;113(8):E1026–33.
   PubMed Web of Science ®Google Scholar
• Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccine Immunol. 2008 Jul;15(7):1095–1105.
   PubMed Web of Science ®Google Scholar
• Thornton CR. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin Vaccin Immunol. 2008;15(7):1095–1105.
   PubMed Web of Science ®Google Scholar
• Mercier T, Schauwvlieghe A, de Kort E, et al. Diagnosing invasive pulmonary aspergillosis in hematology patients: a retrospective multicenter evaluation of a novel lateral flow device. J Clin Microbiol. 2019 Apr;57(4). doi:10.1128/JCM.01913-18.
   Web of Science ®Google Scholar
• Wiederhold NP, Thornton CR, Najvar LK, et al. Comparison of lateral flow technology and galactomannan and (1->3)-beta-D-glucan assays for detection of invasive pulmonary aspergillosis. Clin Vaccin Immunol. 2009;16(12):1844–1846.
   PubMedGoogle Scholar
• White PL, Parr C, Thornton C, et al. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. J Clin Microbiol. 2013;51(5):1510–1516.
   PubMed Web of Science ®Google Scholar
• Dufresne SF, Datta K, Li X, et al. Detection of urinary excreted fungal galactomannan-like antigens for diagnosis of invasive aspergillosis. PloS One. 2012;7(8):e42736.
   PubMed Web of Science ®Google Scholar
• Marr KA, Datta K, Mehta S, et al. Urine antigen detection as an aid to diagnose invasive aspergillosis. Clin Infect Dis. 2018 Nov 13;67(11):1705–1711.
   PubMed Web of Science ®Google Scholar
• D’Ordine RL, Garcia KA, Roy J, et al. Performance characteristics of Fungitell STAT™, a rapid (1→3)-β-D-glucan single patient sample in vitro diagnostic assay. Med Mycol. 2020 May 13. DOI:10.1093/mmy/myaa028.
   PubMed Web of Science ®Google Scholar
• Hoenigl M. Fungal translocation: A driving force behind the occurrence of non-AIDS events? Clin Infect Dis. 2020;70(2):242–244. DOI:10.1093/cid/ciz215
   Google Scholar
• Hoenigl M, Perez-Santiago J, Nakazawa M, et al. (1–>3)-beta-d-glucan: A biomarker for microbial translocation in individuals with acute or early HIV infection? Front Immunol. 2016;7:404.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Moser CB, Funderburg N, et al. Soluble urokinase plasminogen activator receptor is predictive of non-AIDS events during antiretroviral therapy-mediated viral suppression. Clin Infect Dis. 2019;69(4):676–686.
   PubMed Web of Science ®Google Scholar
• Hoenigl MJ, Spiess B, Buchheidt D, et al. Performance of the bronchoalveolar lavage fluid aspergillus galactomannan lateral flow assay with cube reader for diagnosis of invasive pulmonary aspergillosis: a multicenter mixed cohort study. 2020;ciaa1281. DOI:10.1093/cid/ciaa1281
   Google Scholar
• Thornton C, Johnson G, Agrawal S. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology. J Vis Exp. 2012;61:pii: 3721. DOI:10.3791/3721
   PubMed Web of Science ®Google Scholar
• Prattes J, Koidl C, Eigl S, et al. Bronchoalveolar lavage fluid sample pretreatment with Sputasol((R)) significantly reduces galactomannan levels. J Infect. 2015;70(5):541–543.
   PubMed Web of Science ®Google Scholar
• Heldt S, Eigl S, Prattes J, et al. Levels of interleukin (IL)-6 and IL-8 are elevated in serum and bronchoalveolar lavage fluid of haematological patients with invasive pulmonary aspergillosis. Mycoses. 2017;60(12):818–825.
   PubMed Web of Science ®Google Scholar
• Eigl S, Prattes J, Reinwald M, et al. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test. Int J Antimicrob Agents. 2015;46(4):401–405.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Prattes J, Spiess B, et al. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2014;52(6):2039–2045.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Koidl C, Duettmann W, et al. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J Infect. 2012;65(6):588–591.
   PubMed Web of Science ®Google Scholar
• Johnson GL, Sarker SJ, Nannini F, et al. Aspergillus-specific lateral-flow device and real-time PCR testing of bronchoalveolar lavage fluid: a combination biomarker approach for clinical diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol. 2015;53(7):2103–2108.
   PubMed Web of Science ®Google Scholar
• Castillo CG, Kauffman CA, Zhai J, et al. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients. Mycoses. 2018;61(1):4–10.
   PubMed Web of Science ®Google Scholar
• Miceli MH, Goggins MI, Chander P, et al. Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis. Mycoses. 2015;58(6):368–374.
   PubMed Web of Science ®Google Scholar
• Pan Z, Fu M, Zhang J, et al. Diagnostic accuracy of a novel lateral-flow device in invasive aspergillosis: a meta-analysis. J Med Microbiol. 2015;64(7):702–707.
   PubMed Web of Science ®Google Scholar
• Prattes J, Heldt S, Eigl S, et al. Point of care testing for the diagnosis of fungal infections: are we there yet? Curr fungal infect rep. 2016;10:43–50.
   PubMed Web of Science ®Google Scholar
• Linder KA, Kauffman CA, Zhou S, et al. Clinical application of Aspergillus lateral flow device in bronchoalveolar lavage fluid of patients with classic risk factors for invasive pulmonary aspergillosis. Mycoses. 2019 Dec;62(12):1189–1193.
   PubMed Web of Science ®Google Scholar
• Orasch T, Prattes J, Faserl K, et al. Bronchoalveolar lavage triacetylfusarinine C (TAFC) determination for diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies. J Infect. 2017;75(4):370–373.
   PubMed Web of Science ®Google Scholar
• Denning DW, Page ID, Chakaya J, et al. Case definition of chronic pulmonary aspergillosis in resource-constrained settings. Emerg Infect Dis. 2018;24(8). DOI:10.3201/eid2408.171312
   PubMed Web of Science ®Google Scholar
• Salzer HJF, Prattes J, Flick H, et al. Evaluation of galactomannan testing, the aspergillus-specific lateral-flow device test and levels of cytokines in bronchoalveolar lavage fluid for diagnosis of chronic pulmonary aspergillosis. Front Microbiol. 2018;9:2223.
   PubMed Web of Science ®Google Scholar
• Wahidi MM, Lamb C, Murgu S, et al. American association for bronchology and interventional pulmonology (AABIP) statement on the use of bronchoscopy and respiratory specimen collection in patients with suspected or confirmed COVID-19 infection. J Bronchology Interv Pulmonol. 2020;10.1097/LBR.0000000000000681. DOI:10.1097/LBR.0000000000000681
   Web of Science ®Google Scholar
• Held J, Schmidt T, Thornton CR, et al. Comparison of a novel Aspergillus lateral-flow device and the Platelia((R)) galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. Infection. 2013;41(6):1163–1169.
   PubMed Web of Science ®Google Scholar
• White PL, Price JS, Posso R, et al. Evaluation of the performance of the IMMY sona aspergillus galactomannan lateral flow assay when testing serum to aid in diagnosis of invasive aspergillosis. J Clin Microbiol. 2020 Mar 18;58(6). DOI:10.1128/JCM.00053-20.
   Web of Science ®Google Scholar
• Donnelly JP, Chen SC, Kauffman CA, et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis. 2019 Dec 5. DOI:10.1093/cid/ciz1008.
   PubMed Web of Science ®Google Scholar
• Haynes KA, Latge JP, Rogers TR. Detection of aspergillus antigens associated with invasive infection. J Clin Microbiol. 1990 Sep;28(9):2040–2044.
   PubMed Web of Science ®Google Scholar
• Ansorg R, Heintschel von Heinegg E, Rath PM. Aspergillus antigenuria compared to antigenemia in bone marrow transplant recipients. Eur J Clin Microbiol Infect Dis. 1994 Jul;13(7):582–589.
   PubMed Web of Science ®Google Scholar
• Duettmann W, Koidl C, Troppan K, et al. Serum and urine galactomannan testing for screening in patients with hematological malignancies. Med Mycol. 2014;52(6):647–652.
   PubMed Web of Science ®Google Scholar
• Reischies FM, Raggam RB, Prattes J, et al. Urine galactomannan-to-creatinine ratio for detection of invasive aspergillosis in patients with hematological malignancies. J Clin Microbiol. 2016;54(3):771–774.
   PubMed Web of Science ®Google Scholar
• Blot SI, Taccone FS, Van den Abeele AM, et al. A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients. Am J Respir Crit Care Med. 2012 Jul 1;186(1):56–64.
   PubMed Web of Science ®Google Scholar
• Cornillet A, Camus C, Nimubona S, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis. 2006;43(5):577–584.
   PubMed Web of Science ®Google Scholar
• Bergeron A, Porcher R, Sulahian A, et al. The strategy for the diagnosis of invasive pulmonary aspergillosis should depend on both the underlying condition and the leukocyte count of patients with hematologic malignancies. Blood. 2012;119(8):1831–1837. quiz 1956..
   PubMed Web of Science ®Google Scholar
• Chindamporn A, Chakrabarti A, Li R, et al. Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: an Asia fungal working group (AFWG) initiative. Med Mycol. 2018;56(4):416–425.
   PubMed Web of Science ®Google Scholar
• Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European confederation of medical mycology in cooperation with the mycoses study group education and research consortium. Lancet Infect Dis. 2019 Nov 4;19(12):e405-e421.
   PubMed Web of Science ®Google Scholar
• Hoenigl M, Gangneux JP, Segal E, et al. Global guidelines and initiatives from the european confederation of medical mycology to improve patient care and research worldwide: new leadership is about working together. Mycoses. 2018;61(11):885–894.
   Web of Science ®Google Scholar